In this setting, pro-survival autophagy inhibitors, able to block autophagosome or autolysosome generation, and pro-death autophagy inducers, modulating mTOR-related and unrelated autophagic mechanisms, have proved to be useful against melanoma [90, 146]. This evidence concerns the gene MTOR and melanoma.